Literature DB >> 26361336

Development of an Educational Strategy and Decision Support Tool to Enhance Appropriate Use of Stress Echocardiography at a Large Academic Medical Center: A Prospective, Pre- and Postintervention Analysis.

Kevin Levitt1, Jeremy Edwards2, Chi-Ming Chow2, R Sacha Bhatia3.   

Abstract

BACKGROUND: Despite previous studies demonstrating suboptimal appropriate use of stress echocardiography (SE), few interventions have been demonstrated to improve its appropriate use. The aim of this study was to develop a novel mechanism to improve the appropriateness of SE by implementing a point-of-care decision support tool and ordering requisition coupled with an educational strategy.
METHODS: A prospective pre- and postintervention analysis was conducted. The intervention included education and the development and implementation of novel ordering requisition coupled with a decision support tool that integrated appropriate use criteria (AUC) for SE.
RESULTS: In the baseline period, 256 consecutive stress echocardiographic studies were evaluated, and 97% were classifiable by the 2011 AUC. During the intervention period, 159 studies were evaluated (98% classifiable). The intervention resulted in an increase in the appropriate proportion from 65% to 76% and a reduction in the rarely appropriate proportion from 31% to 19% (P = .017). After adjustment for physician specialty, the postintervention period had lower odds of rarely appropriate testing (0.54; 95% CI, 0.3-0.95; P = .04). Cardiology had significant lower odds of rarely appropriate testing (0.23; 95% CI, 0.11-0.50; P < .001) compared with family practice (the reference standard). Vascular surgery had the highest odds (5.76; 95% CI, 2.18-21.52; P = .002) of rarely appropriate testing.
CONCLUSION: AUC have not previously been applied to SE in a single-payer, publicly funded health system. The development of an educational intervention involving a new requisition and decision support tool that integrated AUC resulted in a significantly reduced proportion of rarely appropriate SE. Cardiologists ordered the highest proportion of appropriate SE. Further study is needed to determine the generalizability of the results.
Copyright © 2015 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Keywords:  Appropriate use; Decision support tool; Stress echocardiography

Mesh:

Year:  2015        PMID: 26361336     DOI: 10.1016/j.echo.2015.08.003

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  4 in total

1.  Effects of an Electronic Medical Record Intervention on Appropriateness of Transthoracic Echocardiograms: A Prospective Study.

Authors:  Weihan Chen; David T Saxon; Michael P Henry; John R Herald; Rob Holleman; Debbie Zawol; Stacy Sivils; Mohamad A Kenaan; Theodore J Kolias; Hitinder S Gurm; Nicole M Bhave
Journal:  J Am Soc Echocardiogr       Date:  2020-11-01       Impact factor: 5.251

Review 2.  Appropriate Use Criteria for Echocardiography: Evolving Applications in the Era of Value-Based Healthcare.

Authors:  Amita Singh; R Parker Ward
Journal:  Curr Cardiol Rep       Date:  2016-09       Impact factor: 2.931

3.  Appropriate use criteria for echocardiography in the Netherlands.

Authors:  B J Bouma; R Riezenbos; A J Voogel; M H Veldhorst; W Jaarsma; J Hrudova; B Cernohorsky; S Chamuleau; R B A van den Brink; R Breedveld; C Reichert; O Kamp; R Braam; J P van Melle
Journal:  Neth Heart J       Date:  2017-05       Impact factor: 2.380

4.  Association Between Physicians' Appropriate Use of Echocardiography and Subsequent Healthcare Use and Outcomes in Patients With Heart Failure.

Authors:  Tharmegan Tharmaratnam; Zachary Bouck; Atul Sivaswamy; Harindra C Wijeysundera; Cherry Chu; Cindy X Yin; Gillian C Nesbitt; Jeremy Edwards; Kibar Yared; Brian Wong; Adina Weinerman; Paaladinesh Thavendiranathan; Harry Rakowski; Paul Dorian; Geoff Anderson; Peter C Austin; David M Dudzinski; Dennis T Ko; Rory B Weiner; R Sacha Bhatia
Journal:  J Am Heart Assoc       Date:  2019-12-24       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.